The challenged biotech firm, NovaGen Therapeutics, faced critical monetary difficulties stemming from disappointing clinical trials and escalating debt. Their internal management lacked the expertise to https://albieopiw704402.blogdigy.com/biotech-cfo-services-a-case-study-in-fiscal-restructuring-66055428